Application of the American Heart Association/American College of Cardiology/Heart Failure Society of America Heart Failure Staging Guidelines in Adults With Chronic Kidney Disease.

ABSTRACT:

Background

In 2022 the American Heart Association/American College of Cardiology/Heart Failure Society of America Guidelines for Management of Heart Failure proposed an updated staging system with cardiac biomarkers to diagnose heart failure (HF) and its severity. The applicability of this staging system in chronic kidney disease is not well established.

Methods

This is a prospective cohort study of 2415 participants from CRIC (Chronic Renal Insufficiency Cohort). Individuals were classified into HF stages using 2013 and 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America HF guidelines using research echocardiograms, cardiac biomarkers (troponin T ≥10 ng/L [women], ≥15 ng/L [men], pro-B-type natriuretic peptide ≥125 pg/mL), laborat

SUBMITTER: Zemke AM 

PROVIDER: S-EPMC12533605 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature